OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 51 filers reported holding OVID THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $548,576 | +17.1% | 142,858 | +0.0% | 0.00% | – |
| Q2 2023 | $468,509 | +27.1% | 142,838 | 0.0% | 0.00% | – |
| Q1 2023 | $368,522 | +549932.8% | 142,838 | +300.1% | 0.00% | – |
| Q4 2022 | $67 | -99.9% | 35,704 | -14.4% | 0.00% | – |
| Q3 2022 | $77,000 | +26.2% | 41,720 | +113.2% | 0.00% | – |
| Q1 2022 | $61,000 | -3.2% | 19,564 | 0.0% | 0.00% | – |
| Q4 2021 | $63,000 | -79.2% | 19,564 | -63.0% | 0.00% | – |
| Q3 2020 | $303,000 | -22.1% | 52,819 | 0.0% | 0.00% | – |
| Q2 2020 | $389,000 | +111.4% | 52,819 | -14.5% | 0.00% | – |
| Q1 2020 | $184,000 | -51.1% | 61,794 | -31.9% | 0.00% | – |
| Q4 2019 | $376,000 | +27.9% | 90,701 | 0.0% | 0.00% | – |
| Q3 2019 | $294,000 | +75.0% | 90,701 | 0.0% | 0.00% | – |
| Q2 2019 | $168,000 | +4.3% | 90,701 | 0.0% | 0.00% | – |
| Q1 2019 | $161,000 | -23.7% | 90,701 | +3.9% | 0.00% | – |
| Q4 2018 | $211,000 | -52.5% | 87,257 | +11.5% | 0.00% | – |
| Q3 2018 | $444,000 | – | 78,262 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 2,000,000 | $7,820,000 | 4.09% |
| BVF INC/IL | 6,631,051 | $25,927,000 | 0.97% |
| EcoR1 Capital, LLC | 6,082,200 | $23,781,000 | 0.89% |
| GLOBEFLEX CAPITAL L P | 1,009,125 | $3,946,000 | 0.71% |
| Ikarian Capital, LLC | 1,124,872 | $4,398,000 | 0.36% |
| CHI Advisors LLC | 218,510 | $854,000 | 0.20% |
| Artal Group S.A. | 2,500,000 | $9,775,000 | 0.20% |
| DCF Advisers, LLC | 139,701 | $546,000 | 0.19% |
| Tibra Equities Europe Ltd | 78,700 | $308,000 | 0.10% |
| XTX Topco Ltd | 50,569 | $198,000 | 0.07% |